Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

Pete - I think K would be very, very needed. Intra

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72446
Posted On: 09/02/2013 10:19:26 PM
Avatar
Posted By: seel
Re: petemantx #10847
Pete - I think K would be very, very needed. Intra-arterial administration of chemo drugs has been huge treatment progress for these kids - but the meds being administered this way are still the harsh chemotherapeutic agents we're used to. Because they are being delivered directly to the ocular site - the systemic risks and side effects have been reduced dramatically - but who wants these agents going into their kids bodies? If a much safer, much less toxic alternative came around with equal or better efficacy - what parent wouldn't choose it?
The hereditary form of this disease is so dangerous. Clinicians have their hands tied. These kids are much higher risk, get hit earlier, get hit in both eyes most often, get secondary cancers at high rates...They need to be treated aggressively, often need a mutiple chemo-regimen that can have side effect of...(wait for it!)...CANCER - in the form of leukemia. Also they sometimes (rare but still happens) need radiation even though radiation is known to increase risk for later cancers, a risk already so high for them. So - in this group of kids with error in the RB1 gene, with hereditary retinoblastoma, Kevetrin could be a godsend. It could give them full body coverage without the system poisoning of chemo. It could prevent radiation treatment in those most unfortunate of children whose illnesses still force them to make that choice.
Also - the chance exists that with Kevetrin, those kids with hereditary retinoblastoma may have decreased risk of pineal gland and other cancers. All supposition. So early in testing to be making any such claims. Just a dream for now - we have no idea if this will be possible.


(0)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us